Stephen Wright thinks a combination of dividends and share buybacks means the Barclays share price is still attractive, ...

The Barclays share price has seen a strong resurgence in 2024 after years out in the cold. Can 2025 carry on the upwards ...

Barclays stock (NYSE: BCS) has gained about 70% year-to-date, as compared to the 25% rise in the S&P500 over the same period.

Barclays analyst Gena Wang raised the firm’s price target on Bluebird Bio (BLUE) to $40 from $2 and keeps an Overweight rating on the shares.

operating in the sector and classified as a on the bse, currently has its share price at The stock has experienced fluctuations today, with a low of ₹ and a high of ₹ Over the past 52 weeks ...

For the 15 Wall Street professionals affected, the termination erased potential bonuses that typically reach up to $1 million ...

Barclays has lost a legal battle linked to the growing car finance mis-selling scandal, in a fresh setback for banks facing ...

Barclays lowered the firm’s price target on Revance (RVNC) to $3 from $7 and keeps an Equal Weight rating on the shares.Don't Miss Our ...

Barclays is a top pick for investors in 2024, with strong performance and growth potential despite some projected challenges.

Barclays on Tuesday lost its bid to overturn a key ruling on motor finance commission, in a case likely to affect a potential ...

It indicates an expandable section or menu, or sometimes previous / next navigation options. Affiliate links for the products on this page are from partners that compensate us and terms apply to ...